Uses of pharmacovigilance databases: An overview

2020/02/26 by Kévin Bihan, Bénédicte Lebrun‐Vignes, Bénédicte Lebrun-Vignes +4 · 167 citations
Computer Science · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Computational Drug Discovery Methods #Computer science #Database #Drug #Drug-Induced Adverse Reactions #Medicine #Pharmacology #Pharmacovigilance #Pharmacovigilance and Adverse Drug Reactions

paper · doi:10.1016/j.therap.2020.02.022

published in Therapies 75(6), 591-598 (Elsevier BV)

openalex publication_date 2020/02/26 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Cardiovascular toxicities associated with immune checkpoint inhibitors
• Case–non-case studies: Principle, methods, bias and interpretation

Cited by

• Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis
• Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis
• "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. [europepmc]
• A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. [europepmc]
• Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic. [europepmc]
• Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System. [europepmc]
• Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors. [europepmc]
• Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study. [europepmc]
• The role of data science in healthcare advancements: applications, benefits, and future prospects. [europepmc]
• The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process. [europepmc]
• Pharmacovigilance in China: Evolution and future challenges. [europepmc]
• Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study. [europepmc]
• Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database. [europepmc]
• Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance. [europepmc]
• Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years. [europepmc]
• Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022. [europepmc]
• The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database. [europepmc]
• Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns. [europepmc]
• Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database. [europepmc]
• New Adverse Drug Reaction Signals from 2017 to 2021-Genuine Alerts or False Alarms? [europepmc]
• Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma ® ) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System. [europepmc]
• Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns. [europepmc]
• Challenges and opportunities of big data analytics in healthcare. [europepmc]
• Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis. [europepmc]
• Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase. [europepmc]
• Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models. [europepmc]
• Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors. [europepmc]